Lp(a) Total Solution
(latex enhanced immune turbidimetry)
Lipoprotein (a)[Lp(a)] consists of low-density lipoprotein (LDL)-like particles and apolipoprotein a[Apo(a)], which are covalently bound by disulfide bonds. The level of plasma Lp(a) is mainly determined by genes and is basically not affected by age, gender, nutrition, environmental factors and drugs. It is an independent risk factor for cardiovascular disease.
Product information
The core advantage of the roof

Total Solution suit Contents
| Item No. |
Specifications |
Remarks |
| LD-Lpa-01 |
75 ml |
Reagent ratio: R1:R2 = 4:1 |
| / |
6x1 mL |
Liquid |
| / |
2x1 mL |
Liquid |
| LD-gpAb-Lpa-01 |
10 mg |
Antibody |
| LD-Ag-Lpa |
5 mg |
natural protein |
| LD-Dil-04 |
50 ml |
|
| LD102029 |
5 ml |
Carboxyl content: 0.12-0.16 (mmol/g) |
| / |
0.5 ml |
|

Total Solution suit Usage Process

Lp(a) preparation material and scheme
| Steps |
Item Name |
Dosage (1ml concentrated system) |
| activation |
Solution H-1 |
750 uL |
| Microspheres (PL120,10%) |
125 μL |
|
| EDC |
5 μL |
|
| coupling |
Lp(a)抗体(LD-gpAb-Lpa-01) |
1.875 mg |
| Closed |
Sealant |
20 μL |
| centrifugal resuspension |
Centrifuge/15min, then resuspend 1mL of solution S-2b |
|
| Ultrasound |
3# horn, 50% power, ultrasonic 5-10min |
|
| Dilution |
Concentrate: solution S-2b = 1:3-1:6 |
|
| Aging |
50 ℃, 12h |
|
Product performance display
| Calibration | Precision |
![]() |
![]() |
| Linear | Clinical relevance |
![]() |
![]() |
| Stability | |
| 1. Reagent open bottle stability
|
2. Accelerated stability
|
Lp (a) Calibrator/Control Performance
| freeze-thaw stability | Accelerated Stability at 37°C |
![]() |
![]() |
After-sales service
Nanjing Liding Medical Technology Co., Ltd.







